Endocrine Society Joins Leading Women’s Health Organizations to Endorse National Strategy to Close the Women’s Health Gap

Women make up more than half of the U.S. population, yet too often their health needs are ignored or minimized.  

On Sept. 29, the Endocrine Society’s staff joined representatives from the Society for Women’s Health Research (SWHR), the American College of Obstetricians & Gynecologists (ACOG), and the Women First Research Coalition (WFRC), and other representatives of the endorsing organizations on Capitol Hill to support the National Strategy to Close the Women’s Health Gap.

The Endocrine Society’s manager, health policy and advocacy, Mya Walters (center) in front of the office of Rep. Julie Fedorchak (R-ND) with Anna Day, grassroots advocacy coordinator, Autoimmune Association (left) and Carly Léon, manager, Health Policy and Government Affairs, Society of Gynecologic Oncology (SGO).

The organizations joined together to educate members of Congress on our call for a bold, strategic $20 billion, 10-year investment into women’s health research. The strategy was unveiled in July, and the Society endorsed it along with more than 20 organizations. 

The National Institutes of Health (NIH) Revitalization Act of 1993 offered an important step forward in women’s health by requiring the inclusion of women in NIH–funded clinical research, but significant gaps in women’s health research, clinical care, and implementation remain. The National Strategy aims to close the women’s health gap across five key priorities: 

  • Research and innovation 
  • Regulatory coordination and modernization 
  • Data and evidence infrastructure 
  • Bolstering the women’s health clinical and research workforce 
  • Public awareness and education 

Read more about the National Strategy at: swhr.org/nationalstrategy. 


TOPICS IN THIS ARTICLE:

Share this article